<DOC>
	<DOCNO>NCT00883480</DOCNO>
	<brief_summary>This pharmacogenic , prospective , multicenter study patient advance lung adenocarcinoma .</brief_summary>
	<brief_title>Individualized Treatment Based Epidermal Growth Factor Receptor Mutations Level BRCA1 Expression Advanced Adenocarcinoma</brief_title>
	<detailed_description>Pharmacogenomic study , prospective , multicenter . Individualized treatment base EGFR mutation level BRCA1 expression patient advance lung adenocarcinoma</detailed_description>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Erlotinib Hydrochloride</mesh_term>
	<criteria>Patients age 18 year . Histologically confirm diagnosis nonsmallcell lung carcinoma . ( indifferentiated BAC histology ) . Only patient advanced disease , define stage IV IIIB with/without pleural effusion , include . Tumor sample available . A measurable lesion , define RECIST criterion . Karnofsky score 60 % ( ECOG &lt; 2 ) . Patients receive previous treatment chemotherapy agent disseminate disease . Chemotherapy allow initial diagnosis patient limit disease patient receive adjuvant neoadjuvant treatment . Patients cerebral disease permit , without time limitation holocranial irradiation complementary antiedema treatment . Patients hepatical , renal hematology normality value . Patients sign inform consent form inclusion study specifies clinical trial treatment entails consent analysis biological sample tumor blood . Patients childbearing age either sex must use effective contraceptive method ( barrier method birth control method ) enter study participate study . Patients must available clinical followup.. Patients receive investigational medicinal product 21 day inclusion study antiEGFR receptor agent . Severe comorbidity .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>NSCLC</keyword>
</DOC>